Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Indirect Pulp Cap: later-stage trial registry

1 of 2 indexed Indirect Pulp Cap trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Indirect Pulp Cap: 2 US clinical trials tracked, 1 recruiting.

Indirect Pulp Cap is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Geisinger Clinic, running 1 of these trials.

Enrollment posture brief

Registry condition indirect-pulp-cap

OPEN 1 | RECR 50% | LATE 2 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Indirect Pulp Cap (this)50%
Open-enrollment share among volume-matched conditions near Indirect Pulp Cap

Indirect Pulp Cap lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Indirect Pulp Cap on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Indirect Pulp Cap is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 42

Phase Distribution

PhaseTrial count
Phase 4 2

Top Sponsors

Named interventions

Most-linked intervention names on Indirect Pulp Cap records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vitrebond Device
1 trials
Biodentin Drug
1 trials
Mineral Trioxide Aggregate Drug
1 trials
mineral trioxide aggregate (MTA) Biological
1 trials
Biodentine Device
1 trials

US sites by state

Facility locations filed on Indirect Pulp Cap trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Indirect Pulp Cap page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Indirect Pulp Cap trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Geisinger Clinic sponsors the most Indirect Pulp Cap trials on record, review their full trial history before evaluating a specific study. See Geisinger Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Indirect Pulp Cap condition card totals 2 registered trials; most-linked intervention Vitrebond; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.